Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever

Vaccine development is a top priority in malignant catarrhal fever (MCF) research. In the case of sheep-associated MCF (SA-MCF) caused by ovine herpesvirus 2 (OvHV-2), progress toward this objective has been hindered by the absence of methods to attenuate or modify the virus, since it cannot be propagated in vitro. As an alternative for vaccine development, in this study, we tested the hypothesis that one of the SA-MCF vaccine candidate targets, OvHV-2 glycoprotein B (gB), could be expressed by a nonpathogenic alcelaphine herpesvirus 1 (AlHV-1) and then evaluated the potential of the AlHV-1/OvHV-2 chimera to be used as a vaccine and a diagnostic tool. ABSTRACT Vaccine development is a top priority in malignant catarrhal fever (MCF) research. In the case of sheep-associated MCF (SA-MCF) caused by ovine herpesvirus 2 (OvHV-2), progress toward this objective has been hindered by the absence of methods to attenuate or modify the virus, since it cannot be propagated in vitro. As an alternative for vaccine development, in this study, we tested the hypothesis that one of the SA-MCF vaccine candidate targets, OvHV-2 glycoprotein B (gB), could be expressed by a nonpathogenic alcelaphine herpesvirus 1 (AlHV-1) and then evaluated the potential of the AlHV-1/OvHV-2 chimera to be used as a vaccine and a diagnostic tool. The construction and characterization of an AlHV-1/OvHV-2 chimeric virus that is nonpathogenic and expresses an OvHV-2 vaccine target are significant steps toward the development of an SA-MCF vaccine and also provide a valuable means to study OvHV-2 biology.

[1]  C. Cunha,et al.  Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses , 2015, PloS one.

[2]  A. Nicola,et al.  Antibodies to ovine herpesvirus 2 glycoproteins decrease virus infectivity and prevent malignant catarrhal fever in rabbits. , 2015, Veterinary microbiology.

[3]  W. Azab,et al.  Comparative Analysis of Glycoprotein B (gB) of Equine Herpesvirus Type 1 and Type 4 (EHV-1 and EHV-4) in Cellular Tropism and Cell-to-Cell Transmission , 2015, Viruses.

[4]  D. Knowles,et al.  Malignant catarrhal fever: inching toward understanding. , 2014, Annual review of animal biosciences.

[5]  D. O'Toole,et al.  The Pathology of Malignant Catarrhal Fever, With an Emphasis on Ovine Herpesvirus 2 , 2014, Veterinary pathology.

[6]  D. Knowles,et al.  Are rabbits a suitable model to study sheep-associated malignant catarrhal fever in susceptible hosts? , 2013, Veterinary microbiology.

[7]  S. Roels,et al.  An essential role for γ-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattle , 2013, Proceedings of the National Academy of Sciences.

[8]  A. Nicola,et al.  Development of an in vivo system to measure antibody-blocking of ovine herpesvirus 2 entry. , 2013, Journal of virological methods.

[9]  J. Benavides,et al.  Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever , 2012, Veterinary Research.

[10]  R. Eisenberg,et al.  Herpes Virus Fusion and Entry: A Story with Many Characters , 2012, Viruses.

[11]  M. Ackermann,et al.  Ex Vivo Bioluminescence Detection of Alcelaphine Herpesvirus 1 Infection during Malignant Catarrhal Fever , 2011, Journal of Virology.

[12]  D. Buxton,et al.  An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever. , 2008, Vaccine.

[13]  J. Stewart,et al.  Proteomic Analysis of Pathogenic and Attenuated Alcelaphine Herpesvirus 1 , 2008, Journal of Virology.

[14]  E. Thiry,et al.  The order Herpesvirales , 2008, Archives of Virology.

[15]  J. Oaks,et al.  A real-time PCR assay for measuring alcelaphine herpesvirus-1 DNA. , 2005, Journal of virological methods.

[16]  U. Koszinowski,et al.  Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. , 2005, The Journal of general virology.

[17]  Nancy A. Jenkins,et al.  Simple and highly efficient BAC recombineering using galK selection , 2005, Nucleic acids research.

[18]  T. McGuire,et al.  A Simpler, More Sensitive Competitive Inhibition Enzyme-Linked Immunosorbent Assay for Detection of Antibody to Malignant Catarrhal Fever Viruses , 2001, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[19]  W. Hahn,et al.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Longnecker,et al.  Failure to complement infectivity of EBV and HSV-1 glycoprotein B (gB) deletion mutants with gBs from different human herpesvirus subfamilies. , 1997, Virology.

[21]  T. Mettenleiter,et al.  Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. , 1995, The Journal of general virology.